Relative to Blood Cancer Awareness Month.

California Assembly Resolution 69 (AR69), introduced by Assembly Member Lisa Calderon, designates September 2025 as Blood Cancer Awareness Month in California. The resolution aims to raise public awareness about blood cancers such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. It highlights the importance of educating the public on the causes, symptoms, treatments, and research advancements related to these diseases. The resolution also acknowledges the efforts of medical and bioscience leaders in developing next-generation treatments and emphasizes the need for community dialogue and education to improve the well-being of Californians. AR69 was adopted unanimously by the Assembly on September 8, 2025, with a vote of 71-0.

The Leukemia & Lymphoma Society (LLS) has been at the forefront of blood cancer research and treatment, investing over $1.3 billion in cancer research, including $16 million in California institutions. Their efforts have led to groundbreaking advancements in immunotherapy, genomics, and personalized medicine, significantly improving patient outcomes. LLS's initiatives during Blood Cancer Awareness Month aim to educate the public about blood cancers and support those affected by these diseases.

No negative media coverage or criticism of AR69 has been identified. The resolution appears to have been well-received, with unanimous support in the Assembly and no reported opposition.

Source: LegiScan roll call vote data.